In the DMF-treated group, although the correlation did not reach statistical significance, a weak-to-moderate positive trend was observed (Spearman’s r s = 0.39, p = 0.059; Figure 8 b). 3.
← all excerpts
CHI3L1 Expression in Neutrophils and Plasma of Multiple Sclerosis Patients: Implications for Pathogenesis and a Potential Biomarker.
1
0.0590
0.0590